TKNO FY 2021 Earnings — Alpha Teknova, Inc. Revenue & Financial Results | Market Cap Arena

TKNOAlpha Teknova, Inc.

$133M

FY 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$37M+17.9% YoY

Gross Profit

$18M47.8% margin

Operating Income

-$12M-32.5% margin

Net Income

-$10M-26.6% margin

EPS (Diluted)

$-0.35

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$29M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$167M

Total Liabilities

$23M

Stockholders' Equity

$143M

Cash & Equivalents

$88M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$37M	$31M	+17.9%
Gross Profit	$18M	$18M	-0.8%
Operating Income	-$12M	$5M	-357.5%
Net Income	-$10M	$4M	-374.6%